MULTIPLE MYELOMA, NEWLY DIAGNOSED
Clinical trials for MULTIPLE MYELOMA, NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA, NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA, NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug combo replace chemo and transplant for multiple myeloma?
Disease control Recruiting nowThis study tests if a drug combination (elranatamab and lenalidomide) can replace high-dose chemotherapy and stem cell transplant for people newly diagnosed with multiple myeloma. About 824 participants will first receive standard induction therapy, then be randomly assigned to e…
Matched conditions: MULTIPLE MYELOMA, NEWLY DIAGNOSED
Phase: PHASE3 • Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a drug combo replace transplant for myeloma? new trial aims to find out
Disease control Recruiting nowThis study compares two approaches for people newly diagnosed with multiple myeloma: a drug combination (elranatamab and daratumumab) versus a stem cell transplant followed by maintenance drugs. The goal is to see which method better eliminates cancer cells deep in the bone marro…
Matched conditions: MULTIPLE MYELOMA, NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated May 08, 2026 12:04 UTC